PDCD1 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

17 results for “PDCD1”

Trials

Dose-Finding Study of PDC31 in Patients With Primary Dysmenorrhea

24 participants · First posted Dec 1, 2010

Expanded Access Treatment Protocol With DCA for Patients With PDCD

First posted Apr 17, 2025

Drugs

Dostarlimab(Jemperli)

Conditions: Advanced Microsatellite Instability High Endometrial Carcinoma, Advanced Mismatch Repair-deficient (dMMR) Endometrial Cancer +4 more

SBI-PDC01

SG611-PDCD5

News

View all 11 →

Machine Learning-Based Immune Risk Score Outperforms Traditional Methods in Predicting Colorectal Cancer Outcomes

UNCOVERseq Sets New Benchmark for CRISPR Off-Target Detection with 97.6% Sensitivity

Machine Learning Model Predicts Colorectal Cancer Prognosis Based on CD4+ T Cell Genes

Page 1 of 2